206 related articles for article (PubMed ID: 22782340)
1. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
[TBL] [Abstract][Full Text] [Related]
2. Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
Clin Exp Metastasis; 2011 Jun; 28(5):479-91. PubMed ID: 21452015
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.
Juengel E; Makarević J; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Neoplasia; 2014 Apr; 16(4):291-300. PubMed ID: 24862756
[TBL] [Abstract][Full Text] [Related]
4. Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.
Tsaur I; Hudak L; Makarević J; Juengel E; Mani J; Borgmann H; Gust KM; Schilling D; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
J Cell Mol Med; 2015 Aug; 19(8):1795-804. PubMed ID: 25808196
[TBL] [Abstract][Full Text] [Related]
5. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
[TBL] [Abstract][Full Text] [Related]
6. Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Waaga-Gasser A; Haferkamp A; Blaheta RA
BMC Cancer; 2011 Aug; 11():375. PubMed ID: 21867506
[TBL] [Abstract][Full Text] [Related]
7. mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro.
Engl T; Rutz J; Maxeiner S; Juengel E; Roos F; Khoder W; Bechstein WO; Nelson K; Tsaur I; Haferkamp A; Blaheta RA
Mol Med Rep; 2017 Nov; 16(5):7064-7071. PubMed ID: 28901501
[TBL] [Abstract][Full Text] [Related]
8. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells.
Juengel E; Engler J; Natsheh I; Jones J; Mickuckyte A; Hudak L; Jonas D; Blaheta RA
BMC Cancer; 2009 May; 9():161. PubMed ID: 19473483
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells.
Wedel S; Hudak L; Seibel JM; Juengel E; Tsaur I; Haferkamp A; Blaheta RA
Cancer Lett; 2011 Feb; 301(1):17-28. PubMed ID: 21122981
[TBL] [Abstract][Full Text] [Related]
10. HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.
Makarević J; Rutz J; Juengel E; Maxeiner S; Mani J; Vallo S; Tsaur I; Roos F; Chun FK; Blaheta RA
Cells; 2018 Sep; 7(9):. PubMed ID: 30200497
[TBL] [Abstract][Full Text] [Related]
11. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.
Lochter A; Navre M; Werb Z; Bissell MJ
Mol Biol Cell; 1999 Feb; 10(2):271-82. PubMed ID: 9950676
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer.
Virtakoivu R; Pellinen T; Rantala JK; Perälä M; Ivaska J
Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628
[TBL] [Abstract][Full Text] [Related]
13. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
[TBL] [Abstract][Full Text] [Related]
14.
Kwon OY; Ryu S; Choi JK; Lee SH
Molecules; 2020 Jun; 25(13):. PubMed ID: 32630092
[No Abstract] [Full Text] [Related]
15. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
16. The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line.
Tsaur I; Makarević J; Hudak L; Juengel E; Kurosch M; Wiesner C; Bartsch G; Harder S; Haferkamp A; Blaheta RA
Cancer Lett; 2011 Dec; 313(1):84-90. PubMed ID: 21925791
[TBL] [Abstract][Full Text] [Related]
17. Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells.
Neal CL; Mckeithen D; Odero-Marah VA
Cell Adh Migr; 2011; 5(3):249-57. PubMed ID: 21478672
[TBL] [Abstract][Full Text] [Related]
18. Laminin deposition to type IV collagen enhances haptotaxis, chemokinesis, and adhesion of hepatoma cells through beta1-integrins.
Torimura T; Ueno T; Kin M; Harad R; Nakamura T; Sakamoto M; Kumashiro R; Yano H; Kojiro M; Sata M
J Hepatol; 2001 Aug; 35(2):245-53. PubMed ID: 11580147
[TBL] [Abstract][Full Text] [Related]
19. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins.
Klominek J; Sumitran Karuppan S; Hauzenberger D
Int J Cancer; 1997 Sep; 72(6):1034-44. PubMed ID: 9378538
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
